Giovanni Crisafulli, PhD
Giovanni Crisafulli, PhD
Bioinformatician, Candiolo Cancer Institute
Verified email at ircc.it
TitleCited byYear
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
G Siravegna, B Mussolin, M Buscarino, G Corti, A Cassingena, ...
Nature medicine 21 (7), 795, 2015
5092015
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
G Siravegna, B Mussolin, M Buscarino, G Corti, A Cassingena, ...
Nature medicine 21 (7), 795, 2015
5092015
Tumor heterogeneity and lesion-specific response to targeted therapy in colorectal cancer
M Russo, G Siravegna, LS Blaszkowsky, G Corti, G Crisafulli, ...
Cancer discovery 6 (2), 147-153, 2016
1782016
Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer
S Arena, B Bellosillo, G Siravegna, A MartÝnez, I Ca˝adas, L Lazzari, ...
Clinical cancer research 21 (9), 2157-2166, 2015
1392015
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
G Germano, S Lamba, G Rospo, L Barault, A Magrý, F Maione, M Russo, ...
Nature 552 (7683), 116, 2017
1082017
Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer
M Russo, S Misale, G Wei, G Siravegna, G Crisafulli, L Lazzari, G Corti, ...
Cancer discovery 6 (1), 36-44, 2016
972016
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
BO Van Emburgh, S Arena, G Siravegna, L Lazzari, G Crisafulli, G Corti, ...
Nature communications 7, 13665, 2016
612016
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF-mutant colorectal cancer
D Oddo, EM Sennott, L Barault, E Valtorta, S Arena, A Cassingena, ...
Cancer research 76 (15), 4504-4515, 2016
492016
Radiologic and genomic evolution of individual metastases during HER2 blockade in colorectal cancer
G Siravegna, L Lazzari, G Crisafulli, A Sartore-Bianchi, B Mussolin, ...
Cancer Cell 34 (1), 148-162. e7, 2018
182018
Genetic evolution of glioblastoma stem‐like cells from primary to recurrent tumor
F Orzan, F De Bacco, G Crisafulli, S Pellegatta, B Mussolin, G Siravegna, ...
Stem Cells 35 (11), 2218-2228, 2017
152017
Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions
G Picco, C Petti, A Centonze, E Torchiaro, G Crisafulli, L Novara, ...
EMBO molecular medicine 9 (3), 293-303, 2017
132017
An extended multi-locus molecular typing schema for Streptococcus pneumoniae demonstrates that a limited number of capsular switch events is responsible for serotypeá…
G Crisafulli, S Guidotti, A Muzzi, G Torricelli, M Moschioni, V Masignani, ...
Infection, Genetics and Evolution 13, 151-161, 2013
132013
Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases
G Siravegna, E Geuna, B Mussolin, G Crisafulli, A Bartolini, D Galizia, ...
ESMO open 2 (4), e000253, 2017
122017
Tumor heterogeneity and lesion-specific response to targeted therapy in colorectal cancer. Cancer Discov. 2016; 6: 147–153. doi: 10.1158/2159-8290
M Russo, G Siravegna, LS Blaszkowsky, G Corti, G Crisafulli, ...
CD-15-1283.[PMC free article][PubMed][Cross Ref], 0
12
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer
D Oddo, G Siravegna, A Gloghini, C Vernieri, B Mussolin, F Morano, ...
British journal of cancer 117 (3), 347, 2017
112017
Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor
G Siravegna, A Sartore-Bianchi, B Mussolin, A Cassingena, A Amatu, ...
Annals of Oncology 28 (6), 1302-1308, 2017
112017
Sequence analysis of 96 genomic regions identifies distinct evolutionary lineages within CC156, the largest Streptococcus pneumoniae clonal complex in the MLST database
M Moschioni, ML Sapio, G Crisafulli, G Torricelli, S Guidotti, A Muzzi, ...
PloS one 8 (4), e61003, 2013
112013
Recovery of acanthosis nigricans under prolonged metformin treatment in an adolescent with normal weight.
M Wasniewska, T Arrigo, G Crisafulli, F Lombardo, MF Messina, ...
Journal of endocrinological investigation 32 (11), 939-940, 2009
102009
Hemolytic crisis in a non-ketotic and euglycemic child with glucose-6-phosphate dehydrogenase deficiency and onset of type 1 diabetes mellitus
ΜF Messina, F Lombardo, G Crisafulli, G Salzano, M Rosano, ...
Journal of Pediatric Endocrinology and Metabolism 17 (12), 1671-1674, 2004
102004
Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer. Cancer Discov. 2016; 6: 36–44. doi: 10.1158/2159-8290
M Russo, S Misale, G Wei
CD-15-0940.[PubMed][Cross Ref], 0
10
The system can't perform the operation now. Try again later.
Articles 1–20